Source: Annual Congress 2005 - Exploring alternative mechanisms and treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Li, L. Nicod, B. De La Giclais, J. Zheng, J. Yuan, G. Zeng, N. Zhong, C. Lin (Guangzhou, China; Bern, Switzerland; Annemasse, France). Bacterial extract (OM-85) preventive effect in chronic bronchitis complicated with COPD. Eur Respir J 2005; 26: Suppl. 49, 3705

Member's Comments

No comment yet.

Related content which might interest you: Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005 Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Molecular epidemiology of acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis Source: Eur Respir Rev 2015; 24: 451-461 Year: 2015 Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis Source: Eur Respir J 2012; 39: 1354-1360 Year: 2012 Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in PROTEKT years 1–5 (1999–2004) Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Correlation between sputum colour and isolation of an infecting organism in patients with acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections Year: 2007 Bacterial infections in patients with acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Efficacy of levofloxacin (LVF) in the treatment of acute exacerbations of chronic bronchitis (AECB) in patients with risk factors Source: Annual Congress 2003 - Acute exacerbations of asthma and COPD Year: 2003 Antibacterial activity of telithromycin (TEL) and comparators against bacterial pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in the PROTEKT study 1999–2002 Source: Eur Respir J 2004; 24: Suppl. 48, 641s Year: 2004 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Are antibiotics useful in acute exacerbations of chronic bronchitis? Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=189 Year: 2004